You are here: Home » Budget » Run-up » Industry
Business Standard

R&D activities in pharma may get tax boost in Budget

Annually, India exports pharmaceutical products worth $ 10 billion

Press Trust of India  |  New Delhi 

Finance Minister may accord enhanced tax incentives for research and development (R&D) activities in the pharmaceutical sector in the forthcoming to be announced on February 28.

In its proposals, the Commerce Ministry has sought "weighted average tax benefit of 400 per cent for activities for the sector", a senior official told PTI.
Read our full coverage on Union Budget

"There is an urgent need to boost in the sector. India is the hub of generic medicines. It contributes significantly to the country's total exports," the official added.

Annually, India pharmaceutical products worth $ 10 billion. The market size of the is around Rs 1 lakh crore.

The need for special financial package for the sector has been highlighted in various fora.

The sector is a capital intensive sector. Besides expenditure, regulatory requirements require large funds, an expert said.

"All quality investments should be treated on par with to provide incentives to the industry," the official added.

First Published: Sun, February 15 2015. 11:17 IST